|
| Status |
Public on Apr 01, 2017 |
| Title |
Benign 9 |
| Sample type |
RNA |
| |
|
| Source name |
Ovarian Tissue
|
| Organism |
Homo sapiens |
| Characteristics |
survival time (months): NA
survival status: ALIVE
tumor stage: NA
|
| Extracted molecule |
total RNA |
| Extraction protocol |
As per manufacturer instruction
|
| Label |
FAMTP
|
| Label protocol |
As per manufacturer instruction
|
| |
|
| Hybridization protocol |
n/a
|
| Scan protocol |
n/a
|
| Description |
Benign Ovarian Mass, Subject 9
microRNA
|
| Data processing |
The raw data were processed using Bioconductor htqpcr package, and normalized using Delta-CT with RNU44 and U6, followed by quantile normalization. MicroRNAs absent in more than 25% of samples were discarded.
Data were processed using the OpenArray Real-Time qPCR Analysis software and exported for analysis using the Applied Biosystems DataAssist Software
|
| |
|
| Submission date |
May 25, 2016 |
| Last update date |
Apr 01, 2017 |
| Contact name |
Ilya Korsunsky |
| E-mail(s) |
ikorsuns@broadinstitute.org
|
| Organization name |
Brigham and Women's Hospital
|
| Department |
Genetics
|
| Lab |
Raychaudhuri
|
| Street address |
77 Avenue Louis Pasteur
|
| City |
Boston |
| State/province |
MA |
| ZIP/Postal code |
02115 |
| Country |
USA |
| |
|
| Platform ID |
GPL17485 |
| Series (1) |
| GSE81873 |
Two microRNA Signatures for Malignancy and Immune Infiltration Predict Overall Survival in Advanced Epithelial Ovarian Cancer |
|
